<![CDATA[Developing A Precision Approach to CAR T-Cell Toxicity Management]]>

Summary

Article discusses challenges in CAR T-cell toxicity management with commentary from a clinical expert on the lack of established true toxicity thresholds. No specific company, drug, trial data, or financial information is mentioned.